Ohira Masahiro, Kawagoe Naoyuki, Kameyama Chisato, Kondou Yuko, Igarashi Madoka, Ueshiba Hajime
Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Toho University Ohashi Medical Center, 2-22-36 Ohashi, Meguro-ku, Tokyo, 153-8515, Japan.
Diabetol Metab Syndr. 2025 Apr 28;17(1):144. doi: 10.1186/s13098-025-01706-8.
Insulin secretion and resistance are key pathophysiological factors in type 2 diabetes. However, only 55% of patients achieve long-term blood glucose treatment goals, highlighting the need to clarify the pathophysiology of type 2 diabetes. While cortisol and aldosterone levels have been linked to insulin secretion and resistance in participants without type 2 diabetes, their role in patients with type 2 diabetes remains unclear. In this study, we aimed to investigate the relationships among insulin secretion, insulin resistance, and cortisol or aldosterone levels in patients with untreated type 2 diabetes.
We retrospectively reviewed 121 patients with untreated type 2 diabetes mellitus. We analyzed the relationships between various clinical parameters, including adrenal hormones, and insulin secretion (homeostatic model assessment [HOMA2-%B]) or insulin resistance (HOMA2-IR). Multiple regression analysis was performed to identify parameters associated with HOMA2-%B or HOMA2-IR.
Spearman's rank correlation coefficient revealed that body weight (BW); body mass index (BMI); estimated glomerular filtration rate; and serum creatinine, uric acid, total cholesterol, high-density lipoprotein cholesterol (HDL-C), sodium, potassium, chloride, fasting blood glucose (FBG), glycated hemoglobin (HbA1c), serum C-peptide, and cortisol levels were significantly correlated with HOMA2-%B. Similarly, BW, BMI, aspartate transaminase levels, alanine transaminase (ALT) levels, triglyceride levels, HDL-C levels, FBG levels, serum C-peptide levels, renin activity, and plasma aldosterone concentration (PAC) were significantly correlated with HOMA2-IR. Multiple regression analysis revealed BMI, HbA1c levels, and cortisol levels as predictors of HOMA2-%B, whereas ALT levels and the PAC were predictors of HOMA2-IR.
Serum cortisol levels are associated with insulin secretion, and the PAC is associated with insulin resistance in patients with untreated type 2 diabetes. These findings suggest that aldosterone blockade may represent a potential therapeutic approach for reducing insulin resistance in patients with type 2 diabetes.
胰岛素分泌和抵抗是2型糖尿病关键的病理生理因素。然而,只有55%的患者能实现长期血糖治疗目标,这凸显了阐明2型糖尿病病理生理学的必要性。虽然在无2型糖尿病的参与者中,皮质醇和醛固酮水平与胰岛素分泌和抵抗有关,但其在2型糖尿病患者中的作用仍不明确。在本研究中,我们旨在调查未经治疗的2型糖尿病患者胰岛素分泌、胰岛素抵抗与皮质醇或醛固酮水平之间的关系。
我们回顾性分析了121例未经治疗的2型糖尿病患者。我们分析了包括肾上腺激素在内的各种临床参数与胰岛素分泌(稳态模型评估[HOMA2-%B])或胰岛素抵抗(HOMA2-IR)之间的关系。进行多元回归分析以确定与HOMA2-%B或HOMA2-IR相关的参数。
Spearman等级相关系数显示,体重(BW)、体重指数(BMI)、估计肾小球滤过率以及血清肌酐、尿酸、总胆固醇、高密度脂蛋白胆固醇(HDL-C)、钠、钾、氯、空腹血糖(FBG)、糖化血红蛋白(HbA1c)、血清C肽和皮质醇水平与HOMA2-%B显著相关。同样,BW、BMI、天冬氨酸转氨酶水平、丙氨酸转氨酶(ALT)水平、甘油三酯水平、HDL-C水平、FBG水平、血清C肽水平、肾素活性和血浆醛固酮浓度(PAC)与HOMA2-IR显著相关。多元回归分析显示,BMI、HbA1c水平和皮质醇水平是HOMA2-%B的预测指标,而ALT水平和PAC是HOMA2-IR的预测指标。
在未经治疗的2型糖尿病患者中,血清皮质醇水平与胰岛素分泌有关,PAC与胰岛素抵抗有关。这些发现表明,醛固酮阻断可能是降低2型糖尿病患者胰岛素抵抗的一种潜在治疗方法。